Anonymous
Guest
Anonymous
Guest
http://www.reuters.com/article/2012/01/25/us-fda-celgene-idUSTRE80O2P020120125
what the hell is happening to this place?
what the hell is happening to this place?
http://www.reuters.com/article/2012/01/25/us-fda-celgene-idUSTRE80O2P020120125
what the hell is happening to this place?
First the MS drug that is killing patients and now this. Way to go Novartis!!
http://www.reuters.com/article/2012/01/25/us-fda-celgene-idUSTRE80O2P020120125
what the hell is happening to this place?
Ant again...who pays the price of greed? Yep...the reps and others who are low on the totem pole. Thanks Management...hope you can sleep well at night knowing the decisions YOU made have hurt several people and their families
These are the risks of the business of medicine. The business YOU decided to be a part of.
from the article "For Novartis, the FDA focused on a "Case Highlights" document that described how well Gleevec worked for a particular patient. The FDA said this was misleading because the document implied the drug would work just as well for other patients"
This is BS, if you are looking for information about a product and see "case highlights" and how something worked for a particluliar patient, you assume it would work exactly the same way for you---your an idiot. FDA overstepping
God it would be so helpful if a company would just teach their reps to understand statistics how they are collected, compiled, and managed.